|
1
|
Buckberg G, Athanasuleas C and Conte J:
Surgical ventricular restoration for the treatment of heart
failure. Nat Rev Cardiol. 9:703–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gnecchi M, Danieli P and Cervio E:
Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol.
57:48–55. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Williams AR and Hare JM: Mesenchymal stem
cells: biology, pathophysiology, translational findings, and
therapeutic implications for cardiac disease. Circ Res.
109:923–940. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dimmeler S and Zeiher AM: Cell therapy of
acute myocardial infarction: open questions. Cardiology.
113:155–160. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hill JM, Dick AJ, Raman VK, et al: Serial
cardiac magnetic resonance imaging of injected mesenchymal stem
cells. Circulation. 108:1009–1014. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao Y, Li T, Wei X, et al: Mesenchymal
stem cell transplantation improves regional cardiac remodeling
following ovine infarction. Stem Cells Transl Med. 1:685–695. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li H, Yu B, Zhang Y, et al: Jagged1
protein enhances the differentiation of mesenchymal stem cells into
cardiomyocytes. Biochem Biophys Res Commun. 341:320–325. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li H, Zuo S, Pasha Z, et al: GATA-4
promotes myocardial transdifferentiation of mesenchymal stromal
cells via up-regulating IGFBP-4. Cytotherapy. 13:1057–1065. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Haghani K, Bakhtiyari S and Nouri AM: In
vitro study of the differentiation of bone marrow stromal cells
into cardiomyocyte-like cells. Mol Cell Biochem. 361:315–320. 2012.
View Article : Google Scholar
|
|
10
|
Burlacu A: Can 5-Azacytidine convert the
adult stem cells into cardiomyocytes? A brief overview. Arch
Physiol Biochem. 112:260–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lai NC, Tang T, Gao MH, et al: Improved
function of the failing rat heart by regulated expression of
insulin-like growth factor I via intramuscular gene transfer. Hum
Gene Ther. 23:255–261. 2012. View Article : Google Scholar :
|
|
12
|
Cai B, Li J, Wang J, et al: MicroRNA-124
regulates cardiomyocyte differentiation of bone marrow-derived
mesenchymal stem cells via targeting STAT3 signaling. Stem Cells.
30:1746–1755. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xing Y, Lv A, Wang L, et al: The
combination of angiotensin II and 5-azacytidine promotes
cardiomyocyte differentiation of rat bone marrow mesenchymal stem
cells. Mol Cell Biochem. 360:279–287. 2012. View Article : Google Scholar
|
|
14
|
Zhao JW, Zhang MR, Ji QY, et al: The role
of slingshot-1 L (SSH1L) in the differentiation of human bone
marrow mesenchymal stem cells into cardiomyocyte-like cells.
Molecules. 17:14975–14994. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Samper E, Diez-Juan A, Montero JA, et al:
Cardiac cell therapy: boosting mesenchymal stem cells effects. Stem
Cell Rev. 9:266–280. 2013. View Article : Google Scholar
|
|
16
|
Tomita S, Li R-K, Weisel RD, et al:
Autologous transplantation of bone marrow cells improves damaged
heart function. Circulation. 100:II247–II256. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Song J, Liu W, et al: Growth and
differentiation of rat bone marrow stromal cells: does 5-AZA
trigger their cardiomyogenic differentiation? Cardiovasc Res.
58:460–468. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Q, Li B, Wang X, et al: Overexpression
of insulin-like growth factor I in mice protects from myocyte death
after infarction, attenuating ventricular dilation, wall stress,
and cardiac hypertrophy. J Clin Invest. 100:1991–1999. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee WL, Chen JW, Ting CT, et al:
Insulin-like growth factor I improves cardiovascular function and
suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy.
Endocrinology. 140:4831–4840. 1999.PubMed/NCBI
|
|
20
|
Buerke M, Murohara T, Skurk C, et al:
Cardioprotective effect of insulin-like growth factor I in
myocardial ischemia followed by reperfusion. Proc Natl Acad Sci
USA. 92:8031–8035. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Muguruma Y, Reyes M, Nakamura Y, et al: In
vivo and in vitro differentiation of myocytes from human bone
marrow-derived multipotent progenitor cells. Exp Hematol.
31:1323–1330. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bartunek J, Croissant JD, Wijns W, et al:
Pretreatment of adult bone marrow mesenchymal stem cells with
cardiomyogenic growth factors and repair of the chronically
infarcted myocardium. Am J Physiol Heart Circ Physiol.
292:H1095–H1104. 2007. View Article : Google Scholar
|
|
23
|
Rommel C, Bodine SC, Clarke BA, et al:
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI (3)
K/Akt/mTOR and PI (3) K/Akt/GSK3 pathways. Nat Cell Biol.
3:1009–1013. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Liu W, Liu Y and Lowe WL Jr: The role of
phosphatidylinositol 3-kinase and the mitogen-activated protein
kinases in insulin-like growth factor-I-mediated effects in
vascular endothelial cells. Endocrinology. 142:1710–1719.
2001.PubMed/NCBI
|
